Undoing the dogma in gene therapy manufacturing
By Cytiva
Gene therapy manufacturing is on the precipice of major change. Are you prepared? In this webinar, leading experts come together to dissect the current challenges and future opportunities in viral vector production. Featuring panelists from industry, academia, and technology providers, the discussion offered a comprehensive look at the evolving landscape of gene therapy manufacturing. With landmark innovations hitting cell line development all the time, notably the ELEVECTA™ platform from Cytiva, the time has come to rethink your approach to gene therapy. Fill in your details to learn how.